Потребителски приноси за Marmaipoln
Направо към навигацията
Направо към търсенето
- 14:31, 19 април 2023 разл ист +7242 Н Dolutegravir Lamivudine As A First-line Routine In A Test-and-treat Setting For Newly Diagnosed People Residing With Hiv Pmc Нова страница: „This retrospective research was conducted from July 2020 to July 2022 at a tertiary hospital in Korea. Those who have been followed up for greater than 12 months had been included. We analyzed the baseline traits, effectiveness, resistant profiles, physique weights, metabolic parameters, and security of DTG/3TC therapy in 151 PLWH, dividing them into the treatment-naïve group and the switching group. The median DTG/3TC remedy durations in the treatment-naï...“ текуща